98120t4 Tinc : I lou and

l.

The nicN@py ol $e

(I)

*d6

Plasnod€sna

Anti.nitotic ll*,loidal drug is

g.

Nitrqtes rct rs va3odilator by

(C) (D)

Calcim oxalate crrstels

(B)

OPV

Medullarr rayg

:

Actilatinc v*c!la. gua.ylyi cy.l.&d Activdting vaslar c}rcIic AMP Iahibitins T}rein€ b@s Acting as dlciun charrel blocteF

(A) vsneni€eift {C) MMR vaeine Th€ sympion3 of

h}lenriftnia

:

id gou! ic .se€irl€d sith abnofmal netabolidm ol

(A) Urea

(B) Pldnidhe

(c) ludne

(D) Aninoscid

i. tla €xtent of onjucatio! (A) Bat[dhhnic slift (C) gypshmni. shilt

lnoress€

1.

(B) (D) :

Th. vlcine which colt{in imctivlted viruaa

6.

ninuteg

of Nur.vonic.

2,

(A) (B)

15

ln C€@l with sep $lution, 6oap

of d doubl€ bond€d Bysten reonlts in

i! wd

(B) tltTerchrcmic (D) HtlMhDnic to

:

:

shift shiit

:

(A) 46 a p@Fahv€ (B) EonuF !h. dsrnt€cr.rt activily ol .h. slulrn (C) Enlane th€ Eieilitty of cMl and wrt€. (DJ EnhaN

the deFrccnt ptupdny ol

ih. ptbduct tP.r.o.l

8.

Penicjllift

acr by

interf€ri.g wiih

:

(R) (D)

s:..nllkai3 (C) Pmtein srnthesis in s pbo* (A)

0.

Ag€lts wit! HLB qlue

(A) (C) 10. l.

ofder

13

b

15 are uscd

Miiosis

c€ll wtlr s!.thesn

ac:

Dmulsjtrns aeent SolubilB,ns agent€

t

(q 11,

Plasma menbrane

make a

pnnary cnulsion ot e volatile oil usins *acia, tbe ratio of oilr waicr

(B) 3:2: (D) 1 :2:

1:2 .1

Th€ v€hicle used in llnctNes

i.

1

r

:

(B) S)ep" (D) PEca

(A) I{ydralcoholic sohtion (C) Cber'D

o.al odha*piiv. !* i. d 30 J€c old lady uder€eing atri'rube@ltr teatbenr stth iifanpicin i du€ io : (A) deln*d absotptiotr of @n.meptiw dlug (B) enhrn@d netabon.n of@trh@ptive &us

12. TIB failnre

oa

(C) i.cesed ttuue binding of o.haeptire drug (D) mnpreaatiDn or dfanpicin *ith [email protected] 13, ttre

nucl€u6

pre*nt

rn the

a*aloid papavorine i!

(A) Phenandrcn€ (C) Pirre.idine 14.

List ol dNgs mnuractured und€. thc seneri.

CA)

(c) 16,

w

spehspy, (A) ppo

(O Eenz 9a/2014

(B)

Inilole

(D)

Be.zvl isoquinoline

nan*

onlv is erven in the $hedule :

(B) (D)

X

In NMn

:

the chebicat shift

R P

t k €xpE$ed in

G)

:

Gtuss

(D) Tdla

ro. sJpoua

aie.rliah.n ln th€ prcFsr "r:

(D) bsis oabacr€nd clrs

i()

is obrained fmm the s€e& of thc plnni bclonFrn8

b $e

f€mily

:

(c) 13,

Glucose.6 lbosphate dehydrocerrs. is an en/,ymc rcquired {o! ihe srsbilitr of

(c) 19.

(D)

8d blood @lls

:

Lvmphmyt s

The tesl solulrod is i€at€d siih a crystal dl r.iorcinol and @nc l1CI and a Fse indicrtNe of ftuctose. Th,s t€sr i. d.lled : (B)

dlou

i3

0))

20.

The y€d id *hich Phsmdcy Act

(c) 21,

:

(B) (D)

r9d5

Aod lddt baciene

(A) (B)

\'!. pe*d

i! cla.aci€rizrd

by lbe

pB*ne

rs{7 1948

of :

Ivl)olic aciil in tho ell wall Ivly@lic acid in th€

pl$n'

ccll n.Ebrane

(C) Gllrcdtunoglycan in ihe ell sqll (D) Muranic acid in lhe €U wau ln Mass spectb{oDy, th€ spectruh i6 obluined dd d pLat of : (ll Molecubr weighi versu6 p€ek heighl (B) concentmtio! w$w peak hetht (C) MoleNl* weicht v€raus deate ol dcfloction or iond (D) Rllati* abunda.e ol ion. v€rru E/e ..tio

,3.

ed (A) lprat opiun brcDide (C) Fol]mbd

An inhdl€d atrticnorin€rgic agent

ib

,btiEa

:

(B) *lbutonol @) Prridosttmine 9A/201.1 tP.T.O,l

2.r.

Th€ aberbent prcperty

(A) rB)

25.

26.

Cauctic mda

ofotton ir

ud

6oda

E

dcred by

Ditur€ Hydrcchto.ic

(D)

A

elutior

nirture cf HNO3 rnd potaasiun chlolate

C@ernnent opiun fdctory i3 Eituatad ai

Cholesteml i6 dylthe6izeil in the body

:

f.on

rE

Atrtnabi.s

29.

A

30.

Nesmuch

(D)

NeN Delhi

(B) Upiib (D) Maloni. coEbiDed

ir

rh€

r.2

(D) r: I0o (D) l:20

s€M for[!n.n ue bobt

ined fmD th€

pre&tuatiE Ned in ophihsl4ic prcp.lrtion. {A) plerrl hercu.ic nit[t o.01% {c) Eethyl p{aben 2%

The t€rpenoid pE6ent in clove oil

rcid

ntio

(C) 1:10

t&

(B)

i

A.eryl

C€$idopa and Isodap,

(A\

onbe. *.ste with:

a.h Bolution

CoA. (c) o-dq-tic ac 27.

the

S.dium hrTochlorik elution

(c)

(A)

tb.ri.g

b

blod ol:

:

(B) s.diu h€nhte 0.2% (D) h€rscl oEphene 0.0r%

I

(D)

EwEnol

31. Licere to. th€ nanu&cllF ofo€
32.

88.

ADino dcid

lsm

which €Dineph.ine E svnthcaiad l

(A) A4i.i.e

(B)

Phenyl ala.in€

(O Trame

(D)

TrYpiophan

Cmorprcnazift

(B)

Pnen]1oid

Ph€nobrbitone

(D)

Phendnne

A drus wnich cau& singiYsl

C,' (c)

Ltper"la'ia

is a nethod for exhactioD of

:

(c)

36.

Malfunchon ofthis eldocine 3land ca@ lfomegAlv:

86.

InlgEst ors,n

io

(c)

88,

'n

rhe bodYrs:

(B) (D)

chalmoosra

on

IR

.pecttu

Blact carechu

(D) Benzin

of a. oesnic liquid c.n b€ taken bv placing it bets€en two pellets da
(Br (c) N.Br (A)

40, Ihe imcow

:

G)

(c) cucsul S9,

Ludss

oidiac a@6t in Pigpo. b . boa$ry nethod for : (B) heplrin (D) dieiblis

An unorganizd dNg having ast i.gebt prcperiv is

(A)

skin

rorms

olenz'T4 aF

ol|d

G)

Kcl

@)

AsNor

:

:

9Er/20lil IP,T,O,l

,lL

Follo!'nc sre the acl'o.s ofQud.o orepr:

(B) ,12. ltr

{3,

th€ assly of Bocic acid. the ecent addcrl to

(A)

hydmchloric

(O

aeiic

One olrhp fouos

ilcr€a*

recepbr

16

(R) (D)

(c) Iidnrte cdnlrul Drug laboratory (A) Chaiabail

Mtue

of botic acid is :

rnhrbrb-y,n nsruts

(A) NMDA 44,

the acidic

nu*le relasnt

(B) clye;n {D) dilute nirri. &id

acid

&id 'nC

Skel€tal

i3 e.rablidhed

AMPA GABA

a!

(c) Lu*nd 16. Sbm,t!

in

(A) (c) 16.

*Ma

leaf is :

Btbia@us -Anodar{ic

ALT atut ]1ST reEls rrc rclat€d to th. .ctivity

of:

(A) Kiilney

(B) SDI€er (D) sealt

(c) Liver 4?,

Asaay

neflod for Tltabins Hyd&chloido LP

e0

{9.

Forn

9a/2Ol,t

iB

:

Gnvinerrr

(c) cednd.y

(D)

Non. aqueous

(A)

St€rcidal sapose.in

(B)

Te.penoid epdcenin

(C)

Quinorine

23 C

ftlrtes to nendacturc ol:

(D)

poyclotrcpic rlrucr

ftnnetry

sap€edn

50,

SulDho.lDirle wed for l@al i.testin,l

(R) sulphcua.idine (D) Sulphacetanide A penicillin shich is betalactamase ie.iats^li and dcid re3istdnt

(B)

(A) Adpicillin (C) Ordcilh 52.

The

rc.ctilie 6!

(A) (C) 53. kviartion

66,

66.

O)

the synthsis oI Aspni.

.E

a

ftothod of

A bil€ acid

equ€stednt:

In areDic

liEii

(B) (D)

Aetic &id Pnenol +Aceli. ..hydridc SaljcyUc ,cid +

:

tesi, th€ pmduct

(A)

hydlo8on sulphide

(c)

sulphur dionde

The Pharmdcy

MethiciNr BeMtnin Periqilii!

:

S.licyli. acid + A@tic anhyd.i.l€ Phenol +Aftlic aciil is

:

rhicl tum

ih€ aercuric chloide p,per yellow to b@n is

Coucjl otlndia

G)

r0 yed8

(D) 6ye@ 5?.

Trt

rr.t.lino hhrh! DFi€o elarhcsis

by btnd:ng to

(B) (D)

(A) 40 s ribooodlr dub uit (C) 60. ribo.on6l sub unit 58.

The.epeutic Drus Moniioring ie indiot€d fof

(A)

(c)

:

503 30s

r

Ircprenolol ftuaenide 96/2014 lP.1_O.l

69.

The

ghuiurll

rM€rence between norphins rnd hercin b that, h€rciD @ntains

:

(A) Two anino sroup. at C3 and CG (B) AcdlyL Er.up and nydroryl gbup si C9.nd C6 rcspeciiv€ly (C) lvo hydnxyl eloups ai C3 and C6 @) 'l\,o aeryr sloups at C3 .nd C6 CO. Fluid ener$

rin

worrs on th€ pri,cipls of

I

(B)

(A) Atrftion dd impact (C) CoDpre66ion lDd imprct 61.

61.

Clev€nge. sppa.atus

63.

64.

(D) Aliitiotr nd dnpb.dion

ir usedfor:

(A)

€stinatioD ot uDsaluration in

(C)

exi.actiotr ofvobde

oils

dil

3d

u*d

(A)

Riddl Waller t€6t i3 streptlracns pyoeEnr

(c)

Peudobonasaarusiloda

O!3anidn

for

iB.rpcr

oloil6 & lats

oo

(B) (D)

6d

(!)

Stlpr'yboeur a!re!!

(B) (D)

l.R. sp€ctr@copy

7"

FlaE€ ioniation detector i3 usd in l

u..il in rabler ndu&.tw (A) MrB@iM di€@te

A lub.tcatrt

llag.ds resgsnt is

(A) (C) 08/2014

FlaDe

plotonehy

:

(B) Irct * (D) Polyvinyl pyNlidore

(C) Mire.yt liE@nur@

65.

det€rmine saponincatioo valu€

:

(A) UV spectMpy (C) G,s.hmn,tocnphy 66.

(B)

(D) $ftd6carion

Oro@nciry oltmmoslrcos'rtp sntibiotics B due to

{C)

ComDresion.nd cutiiry

:

50% iodi@

(B)

&lutio!

Saturated pola$iun iodid€

srturated pidric aci.l.olution

solution (D) Aodic bGmuih

l0

iodide solutio!

6?,

(q 63,

Phamaspeia Ns ediled in rh. t666 .xepi in

The Indian

1990

Suga. moieiy in Oub.in glymside i3

I.t.

In Calanine toiion

?0.

An dtimetabolite

(A)

E)

20ro

(D)

2014

(B)

Clclopbosphlnide

:

glycenn aci d3

lnti cdncr

drug

:

?aditaxel

(D) Met}otrent€

(C) BGilpLan

tl

:

Tne Mber ol@r of gbdd @ntlineB b due

(A) T,rtrazi.e (C)

Cadnium oEde

?2. Wawl€rcth

i.:

or6nse. pnnt re6on

(A) 2.5 - 3.0 rn (C) 0.2 0.35 /n ?s.

A. indicst r fted in omplexoEeiric lit.aiion

ts

In ointEent foBulation, n.crosol baes are wed

ba@s {c) water solubl€ ba*s (A) 76,

Eydrearbon

Schiffs reagent i3 $ed

(A)

ketotre

G)

ar6hol!

ao

det@t

I

I

(B) (D)

Absorpiion bases

wat€! nidbl€

b*.

:

9E/2014

?6.

Li6t of -Araredic poiens

i. giren in encdll€

:

Et (q v

(B) X (D) FandFI

(.a)

??,

One oune =

(o 78,

_

grains,

(B)3 (D)

60

One reasan lor'@pping is

(A)

:

(B) ldadequat lubtuanl u* nelhod of air wiihin the iiblei (D) Overuse ofbindirg agents

Defective sanulatiod

(C) Entiapneni

80.

Dxample ol a prckinetic acetri

:

(B) oetcloprmi.Ie (D) @prMle

(A) otr&n*Eon

(c) c,Ydjzitrd 8r.

.r30

lvho anong lL€ foUwing was lh€

f$i

Covcrld Ge@41 of Brit$h Inilia?

(A) l,rd comw,nis {C) b.a w&En rG*insd a2. l. wiidi dngE$

G) l^dD.lhouie (D l,!d WeUelie

ession Jawlh!.lal Nehru .u@ded Motjlal N€lN as

ih. prcsidelt of

IrdiqD National Concxeoo :

(A) (C) 89.

(B) (D)

19.12 Mail&s session of 1887 Bonbay *6aion of

Kdachi .e6.io! or

1931

Whicl ofthe foUowing Stato oflndia i! called the BotaDiltpu.di!e"? (A) A:su (B) KasLnir

(C) Sikkrn

aa

L€hore €ssionol1929

(A) Alhadia

i! Eurcp6? (B) Anland

(c) cHhoslovarir

O) Grc

WAich

98/t0r4

@) ANm.Ial

dons

the follming is ihe only Mu6lin

t2

Btion

Pmdesh

a5.

Who amons the

lollNing ruler builr ihe fdnon. '(rhardinor'?

(A) (D)

(A) I'ir*shah Tuclak

(c) Auangazeb 36. 1t-" Ind"n n,er

(R) NuDada (D) Indus

(c) Bnhnaputla

Eow nany nenbeB of Rajyasablta sre nomindled by lhe Preiident distinsDished in ad, hle.aiure qnd.@iql $Nicea?

(c) ]6 Who

ano.g th€ lolrdinc .ai&d iLe slog.n "inquil.b 'inilabad" for the 6€t rine? (B) Bhqat.insh L4) Su.y, sed

(D) Chtndeet-hffAzad

(C) v D saErkr.

39.

00,

Whicl uotrs rLe aolldi.g ir th. 6rst b@l publillEd in Malavalai?

pusttutd

(A) VdiL$an. pusthal,n

(B)

I(udas

(O

(D

Chturhiva won.Lxm

veduthtn

sablshepa

The fanous

ThiruwitabLlr rulcr i$u€d

lh.

Sn ClLirhna

Wrich ano4 the lollowina booke

i.

(B) (D)

(c) DarsanaDgrs s@ial

Erodd.

of

Keun Bs,l.kti.hn!

1936 :

Ailvaithapanjaran sivasatalian

lenla stuted ih. s.€[ly "Prablbdalan

(A) M.nnsthladnanalhan

(O

it

noi authored bv Srce NaravqN sttu?

(A) Jaiinimantd

92. wlich

tenplc cDtrv prccbm'tion"

(D) S;ndlan Thiru.er (D) S6fiu LakshEi blai

Tlirunll (C) SwatLiThtunal (A)

s1,

lrcn morsst tle peBon

(B) 6 (D) 12

(A) io 84.

Quliqulubshah

Lnosd as'Tsan p,r in Tb"rrnlonguuR ie

(A) canses 8?.

Shabjahdh

(B) (D)

?

Muhannad AbduLshnan Swad€6hdbhiEani

R.hakis}@pi1lai

'iuai l3

96/t014 tP.T.o.l

93.

66t Indian ele.cd io India. Civil SeFie l (A) S!rendm Mth Bb.nerj* (B) RlvindnnathTaso€ (c) PheMshah M€ntha (D) Badruddin lyabji

who anong the followina wa6 rhe

9,1. Tle indian

(A) Augut (C)

95.

Parlirndnt i. : (B) July 1, 1947

lndejrBnden@ Act passed by tho Blitigh

1947 12, r94?

14,

February

(D)

The 6.st president of l{erala Yuhthivadi Sancan w6E

(A) ravanan Coa which was the parr ofPdtusrl lib€ratad

(A) 1961 who mobg

tle nru@ins Naiional l..der

i6

(A) DdrbhaiN8otuji

(O 94.

rala

Edana.utu

inteslar€d

ni.haE€rl

int

Indirn UnioD

id:

1962 1960 @

rlE "Dimond of

Indi'?

(B) copal,LirhDa C-thale @) Bird Ctddnpal

rajp.rRli

wbo among l!€ lolowinc cicl€tels iool ihe q!ic&c.! 60@ runs and overt oL tLe fo.ner Wesr Indies @crsir Sit Vivirn RichaKbl (A) (u* Sarsalihra (B) vjrar rohli

(C) S&ti. Tendu[ar 99.

!!d

V.T. Bbaiiathnipad

(B) (D)

(c) 1964 97,

:

(B) @)

(c) M.cJ@pb 96.

,ruly 18, t94?

(D)

who anons the 6Uo*ins el€ctad for rhe Odakkuzhal

(A) Balahdiaona

(O

E.R.

(B) (D)

Meera

100. Who anod8 fhe loUowins

i.

9E/2014

Piet€r.

rwdd I 20 13? Bal.chandran

chdtikl.d

susarba.Lunari

alected as ihs ,Per@n of ihe y€ar 20 13" by rhe Tlme Msgzine?

Frsncid (q Nekon Mandeb (A)

Kevin

@rd of

(B) (D)

Pope

la

Snirsoda C!.dhi Bslak Obana

Pharma Chemist - Animal Husbandry.pdf

Page 1 of 12. 98120t4. The nicN@py ol $e *d6 of Nur.vonic. (I) Plasnod€sna. Anti.nitotic ll*,loidal drug is : g. Nitrqtes rct rs va3odilator by : (A) Actilatinc v*c!la. gua.ylyi cy.l.&d. (B) Activdting vaslar c}rcIic AMP. (C) Iahibitins T}rein€ b@s. (D) Acting as dlciun charrel blocteF. Tinc : I lou and 15 ninuteg. (B) Calcim oxalate crrstels.

1MB Sizes 2 Downloads 160 Views

Recommend Documents

pharma science monitor pharmacognostical, preliminary ...
www.pharmasm.com. 90. PHARMA SCIENCE MONITOR. AN INTERNATIONAL JOURNAL OF PHARMACEUTICAL SCIENCES. PHARMACOGNOSTICAL ...

pharma science monitor pharmacognostical, preliminary ...
The mass fragmentation studies revealed the presence ... The free hand cut transverse sections of the seed were taken and ... Statistical analysis was performed using GraphPad In Stat software. RESULTS ..... Email: [email protected].

Aurobindo Pharma (AURPHA) -
Our new target price now stands at | 200 based on 6x FY15E EV/EBITDA. Exhibit 1: .... Exhibit 10: ARV business posts marginal growth of 4% YoY. 175.9. 140.2.

September 2015 Chemist Board Exam School Performance.pdf ...
Page 2 of 2. September 2015 Chemist Board Exam School Performance.pdf. September 2015 Chemist Board Exam School Performance.pdf. Open. Extract.

TSGENCO-Recruitment-Chemist-Posts-Notification.pdf
be treated as “direct recruitee”. 5) AGE: Minimum 18 years & Maximum 44 years. The age is reckoned as on. 01/07/2015 (Rule- 12(1)(a)(v) of State and Subordinate Service Rules). * As per G.O. Ms. No. 329 GA (Ser.A) Dept., Dt. 27/07/2015 and as ado

20170808-purdue-pharma-complaint.pdf
Sign in. Loading… Whoops! There was a problem loading more pages. Retrying... Whoops! There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. 20170808-purdue-phar

20170808-purdue-pharma-complaint.pdf
Whoops! There was a problem loading more pages. Retrying... Whoops! There was a problem previewing this document. Retrying... Download. Connect more apps... Try one of the apps below to open or edit this item. Main menu. Whoops! There was a problem p

Enabling Future Pharma Poster.pdf
@OccultInfection. ○ 1-888-846-2474. Page 1 of 1. Enabling Future Pharma Poster.pdf. Enabling Future Pharma Poster.pdf. Open. Extract. Open with. Sign In.